WITHDRAWN: Inhaled bronchodilators for cystic fibrosis

Cochrane Database Syst Rev. 2016 Feb 11;2(2):CD003428. doi: 10.1002/14651858.CD003428.pub3.

Abstract

This review has been withdrawn because it has been split into the following reviews: 'Long‐acting inhaled bronchodilators for cystic fibrosis' and 'Short‐acting inhaled bronchodilators for cystic fibrosis'.

The editorial group responsible for this previously published document have withdrawn it from publication.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use*
  • Adult
  • Albuterol / analogs & derivatives
  • Albuterol / therapeutic use
  • Bronchial Hyperreactivity / drug therapy*
  • Bronchial Hyperreactivity / etiology
  • Bronchodilator Agents / therapeutic use*
  • Child
  • Cystic Fibrosis / complications*
  • Humans
  • Ipratropium / therapeutic use
  • Randomized Controlled Trials as Topic
  • Salmeterol Xinafoate / therapeutic use

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Salmeterol Xinafoate
  • Ipratropium
  • Albuterol